• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7312
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Codes Vomiting (2144); Convulsion/Seizure (4406)
Date of Event 02/05/2024
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported that she took more than normal insulin based on the high reading obtained with her contour next one meter.No specific reading was provided.The customer was feeling unwell.She stated that she was vomiting and having a seizure.The customer was hospitalized for two days where she was treated.The customer recovered well, however, she is still using the medication for seizure.No further event details were provided.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.
 
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Additional Manufacturer Narrative
The customer did not return the device for evaluation.The contour next test strips associated with the event expired, therefore an in-house testing could not be performed.A device history record was reviewed for the suspected contour next one meter with serial #(b)(6), and no manufacturing anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key18813789
Report Number1810909-2024-00034
Device Sequence Number18219696
Product Code NBW
UDI-Device Identifier10301937312219
UDI-Public10301937312219
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K160682
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date03/31/2024
Device Model Number7312
Device Lot Number2CPEG02A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/12/2024
Supplement Date Received by Manufacturer05/16/2024
Initial Report FDA Received Date03/01/2024
Supplement Report FDA Received Date05/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/01/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age45 YR
Patient SexFemale
-
-